Correlation Between Change of HbA1c, Urinary Glucose Excretion and Other Factors in Patients Treated With Ipragliflozin
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT02791035
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT02791035
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02791035. Allocation not applicable; no masking; primary purpose other. Start 2016-06 (registry gives no type); primary completion 2017-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Correlation Between Change of HbA1c, Urinary Glucose Excretion and Other Factors in Patients Treated With Ipragliflozin
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Oral administration of Ipragliflozin
- Lead sponsor
- Asan Medical Center
- Collaborator
- Severance Hospital
- Collaborator
- Samsung Medical Center
- Collaborator
- Kyung Hee University Hospital at Gangdong
- Collaborator
- Astellas Pharma Korea, Inc.
Record details
- Record id
cardio:ct-nct02791035- Content hash
b6835c80b77080267659b0f9f996245bdf963676683086419f4d77c5aaae3923